These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25410375)

  • 1. Transmucosal delivery of linagliptin for the treatment of type- 2 diabetes mellitus by ultra-thin nanofibers.
    Modgill V; Garg T; Goyal AK; Rath G
    Curr Drug Deliv; 2015; 12(3):323-32. PubMed ID: 25410375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrospun composite nanofiber-based transmucosal patch for anti-diabetic drug delivery.
    Sharma A; Gupta A; Rath G; Goyal A; Mathur RB; Dhakate SR
    J Mater Chem B; 2013 Jul; 1(27):3410-3418. PubMed ID: 32260931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Synergistic Approach: Tazarotene-Calcipotriol-Loaded-PVA/PVP-Nanofibers Incorporated in Hydrogel Film for Management and Treatment of Psoriasis.
    Thakur S; Anjum MM; Jaiswal S; Kumar A; Deepak P; Anand S; Singh S; Rajinikanth PS
    Mol Pharm; 2023 Feb; 20(2):997-1014. PubMed ID: 36630478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained linagliptin administration: superior glycemic control and less pancreatic injury in diabetic rats.
    Zakaria EM; El-Gamal SF; Mahmoud SM; El-Nahas HM; El-Bassossy HM
    Pharm Dev Technol; 2024 Oct; 29(8):874-885. PubMed ID: 39311002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo wound healing performance of drug loaded electrospun composite nanofibers transdermal patch.
    Kataria K; Gupta A; Rath G; Mathur RB; Dhakate SR
    Int J Pharm; 2014 Jul; 469(1):102-10. PubMed ID: 24751731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication and In Vitro/In Vivo Performance of Mucoadhesive Electrospun Nanofiber Mats Containing α-Mangostin.
    Samprasit W; Rojanarata T; Akkaramongkolporn P; Ngawhirunpat T; Kaomongkolgit R; Opanasopit P
    AAPS PharmSciTech; 2015 Oct; 16(5):1140-52. PubMed ID: 25716329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of retinyl acetate from β-cyclodextrin functionalized poly(vinyl alcohol) electrospun nanofibers.
    Lemma SM; Scampicchio M; Mahon PJ; Sbarski I; Wang J; Kingshott P
    J Agric Food Chem; 2015 Apr; 63(13):3481-8. PubMed ID: 25779354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic drug evaluation of empagliflozin plus linagliptin for the treatment of type 2 diabetes.
    Rizos CV; Filippatos TD; Elisaf MS
    Expert Opin Drug Metab Toxicol; 2018 Jan; 14(1):117-125. PubMed ID: 29241374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of linagliptin, a selective dipeptidyl peptidase-4 inhibitor, in the morphine rewarding effects in rats.
    Łupina M; Talarek S; Kotlińska J; Gibuła-Tarłowska E; Listos P; Listos J
    Neurochem Int; 2020 Feb; 133():104616. PubMed ID: 31809774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended duration linagliptin nanoparticles: a novel, safe and effective future of diabetes treatment?
    Hamayal M; Mahmud S; Shahid W
    J Pak Med Assoc; 2024 Oct; 74(10):1916-1917. PubMed ID: 39407403
    [No Abstract]   [Full Text] [Related]  

  • 11. Ofloxacin loaded gellan/PVA nanofibers - Synthesis, characterization and evaluation of their gastroretentive/mucoadhesive drug delivery potential.
    Vashisth P; Raghuwanshi N; Srivastava AK; Singh H; Nagar H; Pruthi V
    Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():611-619. PubMed ID: 27987752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fast dissolving electrospun polymeric films of anti-diabetic drug repaglinide: formulation and evaluation.
    Thakkar S; More N; Sharma D; Kapusetti G; Kalia K; Misra M
    Drug Dev Ind Pharm; 2019 Dec; 45(12):1921-1930. PubMed ID: 31625774
    [No Abstract]   [Full Text] [Related]  

  • 13. Glyxambi--a new combination for type 2 diabetes.
    Med Lett Drugs Ther; 2015 Apr; 57(1467):65-6. PubMed ID: 25897551
    [No Abstract]   [Full Text] [Related]  

  • 14. The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Preserves Endothelial Function in Mesenteric Arteries from Type 1 Diabetic Rats without Decreasing Plasma Glucose.
    Salheen SM; Panchapakesan U; Pollock CA; Woodman OL
    PLoS One; 2015; 10(11):e0143941. PubMed ID: 26618855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal Drug Delivery System of Linagliptin Sustained-release Microparticle Gels:
    Liu J; Guo S; Hong S; Piao J; Piao M
    Curr Drug Deliv; 2024; 21(11):1537-1547. PubMed ID: 38243939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linagliptin-associated blistering and ulceration.
    Psomadakis C; Shahzad N; Katz J
    BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28566414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled Release of Lysozyme Using Polyvinyl Alcohol-Based Polymeric Nanofibers Generated by Electrospinning.
    Ogawa R; Hara K; Kobayashi A; Yoshimura N; Taniguchi Y; Yamazoe E; Ito T; Tahara K
    Chem Pharm Bull (Tokyo); 2024; 72(3):324-329. PubMed ID: 38508743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linagliptin treatment improves cerebrovascular function and remodeling and restores reduced cerebral perfusion in Type 2 diabetes.
    Hardigan T; Yasir A; Abdelsaid M; Coucha M; El-Shaffey S; Li W; Johnson MH; Ergul A
    Am J Physiol Regul Integr Comp Physiol; 2016 Sep; 311(3):R466-77. PubMed ID: 27357799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Architecting novel multilayer nanosponges for co-administration of two drugs managing high-risk type II diabetes mellitus patients suffering from cardiovascular diseases.
    Hammad RW; Sanad RA; Abdelmalak NS; Latif R
    Int J Biol Macromol; 2022 Nov; 220():1429-1443. PubMed ID: 36115452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.